0001387131-18-001513.txt : 20180410 0001387131-18-001513.hdr.sgml : 20180410 20180410175116 ACCESSION NUMBER: 0001387131-18-001513 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180406 FILED AS OF DATE: 20180410 DATE AS OF CHANGE: 20180410 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cannon Louis A CENTRAL INDEX KEY: 0001700257 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37406 FILM NUMBER: 18748814 MAIL ADDRESS: STREET 1: 309 WAVERLEY OAKS ROAD, SUITE 105 CITY: WALTHAM STATE: ME ZIP: 02452 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Corindus Vascular Robotics, Inc. CENTRAL INDEX KEY: 0001528557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 300687898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 309 WAVERLEY OAKS ROAD STREET 2: SUITE 105 CITY: WALTHAM STATE: MA ZIP: 02452 BUSINESS PHONE: 508-653-3335 MAIL ADDRESS: STREET 1: 309 WAVERLEY OAKS ROAD STREET 2: SUITE 105 CITY: WALTHAM STATE: MA ZIP: 02452 FORMER COMPANY: FORMER CONFORMED NAME: Your Internet Defender, Inc DATE OF NAME CHANGE: 20110824 4 1 cannon-form4_040618.xml OWNERSHIP DOCUMENT X0306 4 2018-04-06 0 0001528557 Corindus Vascular Robotics, Inc. CVRS 0001700257 Cannon Louis A 309 WAVERLEY OAKS ROAD, SUITE 105 WALTHAM MA 02452 1 0 0 0 Common Stock 2018-04-06 4 A 0 4687 1.36 A 66955 D Common Stock 7557436 I See Footnote The Common Stock was issued to the reporting person pursuant to the Corindus Vascular Robotics, Inc. Director Compensation Policy in lieu of the reporting person's quarterly retainer and any meeting fees of $6,375. 50,801 shares are held in Cardiac & Vascular Research Center 401k FBO Louis A. Cannon; the remaining shares are held directly. Consists of securities directly owned by BioStar Ventures III, L.P. Dr. Cannon is the founder and Senior Managing Director of BioStar Ventures III, L.P. and, as such, may be deemed to beneficially own the securities held of record by BioStar Ventures III, L.P. for purposes of Rule 16a-1(a). Dr. Cannon disclaims any beneficial ownership of the securities reported, except to the extent of any pecuniary interest therein. /s/ Louis A. Cannon 2018-04-10